WO2012023145A3 - Prasugrel hydrochloride crystalline particles - Google Patents

Prasugrel hydrochloride crystalline particles Download PDF

Info

Publication number
WO2012023145A3
WO2012023145A3 PCT/IN2011/000506 IN2011000506W WO2012023145A3 WO 2012023145 A3 WO2012023145 A3 WO 2012023145A3 IN 2011000506 W IN2011000506 W IN 2011000506W WO 2012023145 A3 WO2012023145 A3 WO 2012023145A3
Authority
WO
WIPO (PCT)
Prior art keywords
crystalline particles
prasugrel hydrochloride
hydrochloride crystalline
prasugrel
particles
Prior art date
Application number
PCT/IN2011/000506
Other languages
French (fr)
Other versions
WO2012023145A2 (en
Inventor
Bandi Parthasaradhi Reddy
Kura Rathnakar Reddy
Dasari Muralidhara Reddy
Rapolu Raji Reddy
Itiyala Srinivas Reddy
Bandi Vamsi Krishna
Original Assignee
Hetero Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Research Foundation filed Critical Hetero Research Foundation
Publication of WO2012023145A2 publication Critical patent/WO2012023145A2/en
Publication of WO2012023145A3 publication Critical patent/WO2012023145A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to prasugrel hydrochloride crystalline particles having mean particle size of more than about 10 µm, to the methods for the manufacture of said crystalline particles, and to pharmaceutical compositions comprising said crystalline particles.
PCT/IN2011/000506 2010-08-18 2011-08-01 Prasugrel hydrochloride crystalline particles WO2012023145A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2377/CHE/2010 2010-08-18
IN2377CH2010 2010-08-18

Publications (2)

Publication Number Publication Date
WO2012023145A2 WO2012023145A2 (en) 2012-02-23
WO2012023145A3 true WO2012023145A3 (en) 2012-06-07

Family

ID=45605479

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2011/000506 WO2012023145A2 (en) 2010-08-18 2011-08-01 Prasugrel hydrochloride crystalline particles

Country Status (1)

Country Link
WO (1) WO2012023145A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105669696B (en) * 2014-11-21 2019-03-26 四川海思科制药有限公司 A kind of prasugrel hydrochloride compound
CN105601643A (en) * 2015-12-23 2016-05-25 山东鲁抗医药股份有限公司 Preparation method of high-purity prasugrel hydrochloride

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030134872A1 (en) * 2000-07-06 2003-07-17 Sankyo Company, Limited Acid addition salts of hydropyridine derivatives
US20090203729A1 (en) * 2006-04-06 2009-08-13 Teruhiko Inoue Process for Producing High-Purity Prasugrel and Acid Addition Salt Thereof
WO2010070677A2 (en) * 2008-12-15 2010-06-24 Glenmark Generics Limited A process for the preparation of prasugrel and its pharmaceutically acceptable salts thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030134872A1 (en) * 2000-07-06 2003-07-17 Sankyo Company, Limited Acid addition salts of hydropyridine derivatives
US20090203729A1 (en) * 2006-04-06 2009-08-13 Teruhiko Inoue Process for Producing High-Purity Prasugrel and Acid Addition Salt Thereof
WO2010070677A2 (en) * 2008-12-15 2010-06-24 Glenmark Generics Limited A process for the preparation of prasugrel and its pharmaceutically acceptable salts thereof

Also Published As

Publication number Publication date
WO2012023145A2 (en) 2012-02-23

Similar Documents

Publication Publication Date Title
WO2011098582A3 (en) Novel crystalline forms of ivabradine hydrochloride
MX364938B (en) Apixaban formulations.
EP2251038A4 (en) Solid dispersion, pharmaceutical compositions containing the same, and processes for the production of both
WO2009066326A3 (en) Improved process for the preparation of prasugrel and its pharmaceutically acceptable salts
IL224288A (en) Derivatives of substituted pyrazolamide, pharmaceutical compositions comprising the same and uses thereof
WO2012021715A3 (en) Stable formulations of linaclotide
WO2010092090A3 (en) Novel salts of sitagliptin
EP2634135A4 (en) Synthesis of molecular sieves for modifying the surfaces of nanoparticles having amphoteric ions, and application thereof
WO2011146583A3 (en) Nanoparticulate cinacalcet formulations
WO2012035283A8 (en) Pharmaceutical composition
WO2011157721A3 (en) Ivabradine-containing pharmaceutical composition
WO2012070062A3 (en) Novel polymorph of nilotinib hydrochloride
WO2013057741A3 (en) Pharmaceutical compositions of ursodeoxycholic acid
WO2014068586A3 (en) Solid oral compositions of tolvaptan
IL227024A (en) Amino-substituted 3-heteroaroylamino-propionic acid derivatives, process for the preparation of such compounds, uses thereof in the preparation of pharmaceuticals and pharmaceutical compositions comprising the same
PL2582359T3 (en) Solid compositions in form of powders or granulates for the oral administration of active ingredients and method for obtaining them
WO2013016205A3 (en) Compositions and methods for reducing the incidence of equine digestive disorders
WO2010006904A3 (en) Crystalline forms of rabeprazole sodium
EP2551266A4 (en) 2',2-dithiazol non-nucleoside compounds, preparation methods, pharmaceutical compositions and uses as hepatitis virus inhibitors thereof
WO2011045760A3 (en) Micronized olmesartan medoxomil compositions
WO2011102702A3 (en) Process for the preparation of oral solid dosage forms comprising valsartan
WO2011052940A3 (en) Process for preparing clopidogrel hydrogensulfate form i
HUP1000565A2 (en) Process for the preparation of pharmaceutically active compound and intermediers
WO2011045774A3 (en) Extended release pharmaceutical compositions of paliperidone and processes of preparation thereof
WO2012168948A3 (en) Process for febuxostat

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11817867

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11817867

Country of ref document: EP

Kind code of ref document: A2